High Serum CA19-9 Concentration Predicts Poor Prognosis in Elderly Patients with Stage IV Colorectal Cancer
Gastrointestinal Tumors · 2018 · 5 (3-4) · 117-124
DOI: 10.1159/000493793 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastrointestinal Tumors, online erschienen am 24.01.2019. Verfasst von Eiji Hidaka und 12 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: The optimal treatment strategy for elderly patients with stage IV colorectal cancer (CRC) remains controversial due to limited research data. The purpose of this study was to evaluate treatment results and to clarify the prognostic factors, especially poor prognosis factors, in elderly patients with stage IV CRC.
Methods
We retrospectively reviewed the data of 82 elderly patients (aged ≥75 years) with stage IV CRC who underwent surgical treatment at our hospital between April 2001 and March 2017. Factors that affected prognosis and the ability to undergo treatment were analyzed via multivariate analysis.
Results
The median overall survival (OS) in the patients with high pretreatment serum carbohydrate antigen 19-9 (CA19-9) concentration (> 370 U/mL) was significantly worse than in those with lower serum CA19-9 concentration (0–370 U/mL) (8.5 vs. 19.2 months, p = 0.0059). In univariate analysis, age (≥80 years) (p = 0.014), performance status of 1–3 (p = 0.028), and high pretreatment serum CA19-9 concentration (p = 0.014) were significant prognostic factors for poor OS. By contrast, resection of the primary tumor (p = 0.024), chemotherapy (p < 0.0001), and resection of distant metastasis (p = 0.0005) were significant prognostic factors for favorable OS. Multivariate analysis showed that a high pretreatment serum CA19-9 concentration was an independent prognostic factor for poor OS (p = 0.01). Meanwhile, resection of the primary tumor (p = 0.033), chemotherapy (p < 0.0001), and resection of distant metastasis (p = 0.0008) were prognostic factors for favorable OS.
Conclusions
A high pretreatment serum CA19-9 concentration (> 370 U/mL) was a reliable predictive factor for poor prognosis, and aggressive treatments should be performed carefully in these patients. Moreover, various treatments, including surgery and chemotherapy, might improve OS in elderly patients with stage IV CRC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan.
Zitieren
APA
Hidaka, E., Maeda, C., Nakahara, K., Wakamura, K., Ishiyama, Y., Shimada, S., Seki, J., Takano, Y., Oae, S., Enami, Y., Sawada, N., Ishida, F., & Kudo, S. E. (2018). High Serum CA19-9 Concentration Predicts Poor Prognosis in Elderly Patients with Stage IV Colorectal Cancer. Gastrointestinal Tumors, 5(3-4), 117-124. https://doi.org/10.1159/000493793
Vancouver
Hidaka E, Maeda C, Nakahara K, Wakamura K, Ishiyama Y, Shimada S, et al. High Serum CA19-9 Concentration Predicts Poor Prognosis in Elderly Patients with Stage IV Colorectal Cancer. Gastrointestinal Tumors. 2018;5(3-4):117-124. doi:10.1159/000493793
BibTeX
@article{Hidaka2018,
author = {Hidaka, Eiji and Maeda, Chiyo and Nakahara, Kenta and Wakamura, Kunihiko and Ishiyama, Yasuhiro and Shimada, Shoji and Seki, Junichi and Takano, Yojiro and Oae, Sonoko and Enami, Yuta and Sawada, Naruhiko and Ishida, Fumio and Kudo, Shin-Ei},
title = {High Serum CA19-9 Concentration Predicts Poor Prognosis in Elderly Patients with Stage IV Colorectal Cancer},
journal = {Gastrointestinal Tumors},
year = {2018},
volume = {5},
number = {3-4},
pages = {117--124},
doi = {10.1159/000493793}
}
EUVIMED